huN# DM1

Related by string. * : testing huN# DM1 / dm1 : trastuzumab DM1 T DM1 . trastuzumab DM1 . Trastuzumab DM1 . compound trastuzumab DM1 . trastuzumab emtansine T DM1 . T DM1 shrank . HP Pavilion dm1 . Pavilion dm1 . HP Pavilion dm1 #nr . assessing T DM1 . evaluating T DM1 . comparing T DM1 . T DM1 . DM1 . agent DM1 . ImmunoGen DM1 cancer * *

Related by context. Frequent words. (Click for all words.) 72 IMGN# 70 relapsed refractory multiple myeloma 70 Phase Ib clinical 69 MEK inhibitor 68 elotuzumab 68 Azedra 68 EZN 68 nab paclitaxel 67 administered subcutaneously 67 HER2 positive metastatic breast 67 Carfilzomib 67 Pivotal Phase III 67 orally bioavailable 67 Gemzar ® 67 pertuzumab 67 CCX# 67 decitabine 66 Sym# 66 Amrubicin 66 Phase 2a trial 66 Cloretazine R VNP#M 66 xenograft models 66 LY# [003] 66 romidepsin 66 PARP inhibitor 66 CA4P 66 axitinib 66 Bortezomib 66 deforolimus 66 DAVANAT 66 OXi# 66 induces apoptosis 65 relapsed multiple myeloma 65 Voreloxin 65 Irinotecan 65 angiogenesis inhibitor 65 eniluracil 65 MORAb 65 anticancer compound 65 SCH # 65 HGS ETR1 65 BAY #-# 65 Phase Ib 65 registrational trial 65 ATL# [001] 65 thymalfasin 65 tanespimycin 65 Zolinza 65 Phase 2a clinical 65 Cethromycin 65 CYC# 65 confirmatory Phase III 64 Gemcitabine 64 Imprime PGG 64 Chronic Lymphocytic Leukemia 64 CR# vcMMAE 64 IMC A# 64 RGB # 64 Trastuzumab 64 luteinizing hormone releasing 64 INGN 64 antitumor activity 64 Lenalidomide 64 Phase IIa clinical 64 PROMACTA 64 octreotide 64 Preclinical studies 64 lymphoma CTCL 64 placebo controlled clinical 64 phase 2a 64 heavily pretreated 64 dose escalation trial 64 Solid Tumors 64 Phase 1b trial 64 dose cohorts 64 AP# [003] 64 HuMax CD# 64 Phase III Clinical Trial 64 phase IIa 64 goserelin 64 Phase 2b study 64 ascending doses 64 BMS # 64 humanized anti 64 humanized monoclonal antibody 64 Acute Myeloid Leukemia AML 64 HCV protease inhibitor 63 Phase 1b 63 Metastatic Melanoma 63 Allovectin 7 R 63 abiraterone acetate 63 double blinded placebo 63 Phase 1b clinical 63 superficial bladder cancer 63 relapsed refractory 63 DOXIL 63 metastatic renal cell carcinoma 63 EORTC 63 PXD# 63 injectable formulation 63 Laquinimod

Back to home page